NCT05805605
- Conditions
- Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Biphenotypic Acute Leukemia, +54 more
- Locations
-
- Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States
Clinical trial condition
Relapsed T-Cell Lymphoma
Explore clinical trials studying Relapsed T-Cell Lymphoma. Study availability and eligibility vary by location and protocol.
5 public trials
1 recruiting study
Relapsed T-Cell Lymphoma trial results
Completed
Reduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic Malignancies
NCT04191187
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Biphenotypic Acute Leukemia, +56 more
- Locations
-
- H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States
NCT02722668
- Conditions
- Acute Leukemia, Acute Lymphoblastic Leukemia/Lymphoma, Acute Myeloid Leukemia, +74 more
- Locations
-
- Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States
NCT03349333
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
- Locations
-
- Beijing Cancer Hospital Beijing, China
Active, Not Recruiting
Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy
NCT03674411
- Conditions
- Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Anemia, +48 more
- Locations
-
- Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States